The Saga of Hydroxychloroquine and COVID-19: A Cautionary Tale.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 32673059.
- Also identified by DOI 10.7326/M20-5041 and PMC identifier 7384271.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In their article, Skipper and colleagues report the results of trial of hydroxychloroquine for patients presenting with nonsevere COVID-19. The editorialists discuss the findings and the need to examine carefully not only what we know about hydroxychloroquine and COVID-19 but also how we learned it, disseminated it, and put it into practice.
Medical subject headings
- Betacoronavirus
- Coronavirus Infections
- Hydroxychloroquine
- Pandemics
- Pneumonia, Viral